ArticleCanadian journal of anaesthesia = Journal canadien d'anesthesie2026
Spontaneous and oxytocin-induced contractility of gravid human myometrium with exposure to intravenous anesthetic agents: an ex vivo laboratory study.
Article in Canadian journal of anaesthesia = Journal canadien d'anesthesie, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThe objective of this study was to investigate the ex vivo effects of various intravenous anesthetic drugs on the contractility of gravid human myometrium. We hypothesized that these drugs would cause a concentration-dependent decrease in spontaneous uterine contractility and oxytocin coadministration would modify their contractile response.
methodsWe conducted an ex vivo laboratory study with individual myometrial strips obtained from patients undergoing elective Cesarean delivery. We subjected the myometrial strips to concentration-response testing in organ bath chambers with intravenous agents-propofol, etomidate, and ketamine, with or without oxytocin-in a pattern of 0.5 log molar increase from 10
resultsThe motility index with each study drug decreased with increasing concentrations. The overall motility index (estimated mean difference [95% confidence interval]) with etomidate (-6% [-77 to -13]; n = 29; P = 0.007) and ketamine (-66% [-82 to -35]; n = 29; P < 0.001) was significantly lower than that of the oxytocin control group, while the difference between propofol and oxytocin was not statistically significant (-38% [-70 to 29]; n = 25; P = 0.47). The addition of oxytocin reversed contractility decreases induced by all anesthetic drugs, with no significant differences observed between the study drug + oxytocin and oxytocin control groups. Nevertheless, when compared with a study drug alone, the addition of oxytocin significantly increased the strength of contraction (area under the curve) of etomidate (207% [30 to 624]; n = 27; P = 0.002) and ketamine (234% [95 to 471]; n = 27; P < 0.001) but not of propofol.
conclusionsAll the studied intravenous anesthetic drugs produced a concentration-dependent decrease in uterine contractility; nevertheless, the addition of oxytocin reversed this effect and increased contractility. Coadministration with oxytocin of etomidate and ketamine, but not propofol, resulted in a significant increase in myometrial contractility.
Indexed as
Identifiers
42231013What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.